News for Healthier Living
Remdesivir for COVID-19 Linked to Better Outcomes for Adult Kidney Transplant Recipients
Adults with kidney transplants who were treated for COVID-19 with the antiviral remdesivir within a week of COVID-19 diagnosis and who received at least three consecutive days of therapy were less likely than kidney transplant recipients who did not receive the antiviral to experience cardiovascular or kidney problems up to a year later, according to findings from a target trial emulation study that published in JAMA Network Open.
July 28, 2026
July 28 2026July 27 2026July 26 2026July 25 2026July 24 2026July 23 2026July 22 2026July 21 2026July 20 2026July 17 2026July 16 2026July 15 2026July 14 2026
|
|
|
|
|